Quadrant Capital Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25
| Closed | -$184 | – | 2707 |
|
|
2023
Q2 | $184 | Sell |
25
-1,341
| -98% | -$9.87K | ﹤0.01% | 2659 |
|
|
2023
Q1 | $14.2K | Buy |
1,366
+451
| +49% | +$4.67K | ﹤0.01% | 1862 |
|
|
2022
Q4 | $10.8K | Buy |
915
+299
| +49% | +$3.53K | ﹤0.01% | 1905 |
|
|
2022
Q3 | $13K | Buy |
616
+511
| +487% | +$10.8K | ﹤0.01% | 1758 |
|
|
2022
Q2 | $3K | Sell |
105
-26
| -20% | -$743 | ﹤0.01% | 2102 |
|
|
2022
Q1 | $5K | Sell |
131
-28
| -18% | -$1.07K | ﹤0.01% | 1901 |
|
|
2021
Q4 | $7K | Sell |
159
-63
| -28% | -$2.77K | ﹤0.01% | 1761 |
|
|
2021
Q3 | $11K | Buy |
222
+21
| +10% | +$1.04K | ﹤0.01% | 1526 |
|
|
2021
Q2 | $13K | Sell |
201
-98
| -33% | -$6.34K | ﹤0.01% | 1429 |
|
|
2021
Q1 | $28K | Buy |
299
+10
| +3% | +$936 | ﹤0.01% | 1028 |
|
|
2020
Q4 | $26K | Buy |
289
+63
| +28% | +$5.67K | ﹤0.01% | 991 |
|
|
2020
Q3 | $23K | Sell |
226
-1,989
| -90% | -$202K | 0.01% | 899 |
|
|
2020
Q2 | $175K | Buy |
2,215
+1,388
| +168% | +$110K | 0.04% | 291 |
|
|
2020
Q1 | $48K | Buy |
827
+38
| +5% | +$2.21K | 0.01% | 899 |
|
|
2019
Q4 | $41K | Hold |
789
| – | – | ﹤0.01% | 1433 |
|
|
2019
Q3 | $39K | Buy |
789
+740
| +1,510% | +$36.6K | 0.01% | 1322 |
|
|
2019
Q2 | $2K | Buy |
+49
| New | +$2K | ﹤0.01% | 2123 |
|
|
2016
Q3 | – | Sell |
-31
| Closed | – | – | 2015 |
|
|
2016
Q2 | $0 | Hold |
31
| – | – | ﹤0.01% | 1995 |
|
|
2016
Q1 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 1482 |
|